republic-os/legislation/us/states/il/104th/sb-3223.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	PRACTICE OF PHARMACY	Amends the Pharmacy Practice Act. Provides that "practice of pharmacy" includes the monitoring of medication recalls, including notifying patients of applicable medication recalls at the point of sale.	us/states/il	Illinois General Assembly	104th	SB 3223	Illinois SB 3223 (104th)	bill		enacted	Doris Turner Mary Gill	6	42	6	2026-02-02	2026-06-26	openstates	ocd-bill/4f159648-7478-4b96-973c-60a3ba029973	https://ilga.gov/Legislation/BillStatus?DocNum=3223&GAID=18&DocTypeID=SB&LegId=165938&SessionID=114	f9a11b59d4dedacd985ebc3d16af91cb975d1719f6ecc68c69fc80cafb88b68d	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-il

Illinois SB 3223 (104th) — PRACTICE OF PHARMACY

Amends the Pharmacy Practice Act. Provides that "practice of pharmacy" includes the monitoring of medication recalls, including notifying patients of applicable medication recalls at the point of sale.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced (filed) — source
2. Engrossed (committee substitute) — source
3. House Amendment 001 (committee substitute) — source
4. Senate Amendment 001 (committee substitute) — source
5. Senate Amendment 002 (committee substitute) — source
6. Enrolled (enrolled) — source

Votes

• Licensed Activities — 8–0 (pass) · upper
• Licensed Activities, Amendment 2 — 8–0 (pass) · upper
• Third Reading — 100–0 (pass) · lower
• Third Reading — 55–0 (pass) · upper
• Prescription Drug Affordability — 13–0 (pass) · lower
• Licensed Activities — 8–0 (pass) · upper

Sponsors

• Doris Turner — primary (person)
• Mary Gill — primary (person)
• Camille Y. Lilly — cosponsor (person)
• Lakesia Collins — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2026-02-02 Filed with Secretary by Sen. Doris Turner filing
• 2026-02-02 First Reading reading-1
• 2026-02-02 Referred to Assignments
• 2026-02-10 Assigned to Licensed Activities referral-committee
• 2026-02-19 Senate Committee Amendment No. 1 Filed with Secretary by Sen. Doris Turner amendment-introduction
• 2026-02-19 Senate Committee Amendment No. 1 Referred to Assignments
• 2026-02-24 Senate Committee Amendment No. 1 Assignments Refers to Licensed Activities
• 2026-03-04 Postponed - Licensed Activities
• 2026-03-04 Senate Committee Amendment No. 1 Postponed - Licensed Activities
• 2026-03-11 Senate Committee Amendment No. 1 Adopted amendment-passage
• 2026-03-11 Do Pass as Amended Licensed Activities; 008-000-000
• 2026-03-11 Placed on Calendar Order of 2nd Reading March 12, 2026 reading-2
• 2026-03-26 Senate Floor Amendment No. 2 Filed with Secretary by Sen. Doris Turner amendment-introduction
• 2026-03-26 Senate Floor Amendment No. 2 Referred to Assignments
• 2026-04-14 Senate Floor Amendment No. 2 Assignments Refers to Licensed Activities
• 2026-04-14 Second Reading reading-2
• 2026-04-14 Placed on Calendar Order of 3rd Reading April 15, 2026
• 2026-04-15 Senate Floor Amendment No. 2 Recommend Do Adopt Licensed Activities; 008-000-000
• 2026-04-16 Recalled to Second Reading reading-2
• 2026-04-16 Senate Floor Amendment No. 2 Adopted; D. Turner amendment-passage
• 2026-04-16 Placed on Calendar Order of 3rd Reading
• 2026-04-16 Third Reading - Passed; 055-000-000 passage, reading-3
• 2026-04-16 Added as Chief Co-Sponsor Sen. Lakesia Collins
• 2026-04-17 Arrived in House introduction
• 2026-04-20 Chief House Sponsor Rep. Mary Gill
• 2026-04-20 First Reading reading-1
• 2026-04-20 Referred to Rules Committee
• 2026-04-27 Assigned to Prescription Drug Affordability & Accessibility Committee referral-committee
• 2026-05-06 Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
• 2026-05-07 Placed on Calendar 2nd Reading - Short Debate reading-2
• 2026-05-19 Second Reading - Short Debate reading-2
• 2026-05-19 Held on Calendar Order of Second Reading - Short Debate reading-2
• 2026-05-21 House Floor Amendment No. 1 Filed with Clerk by Rep. Mary Gill amendment-introduction
• 2026-05-21 House Floor Amendment No. 1 Referred to Rules Committee
• 2026-05-21 Placed on Calendar Order of 3rd Reading - Short Debate
• 2026-05-22 Third Reading - Short Debate - Passed 100-000-000 passage, reading-3
• 2026-05-22 House Floor Amendment No. 1 Tabled amendment-failure
• 2026-05-22 Passed Both Houses
• 2026-05-22 Added Alternate Co-Sponsor Rep. Camille Y. Lilly
• 2026-06-18 Sent to the Governor executive-receipt
• 2026-06-26 Governor Approved executive-signature
• 2026-06-26 Public Act . . . . . . . . . 104-0530 became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/4f159648-7478-4b96-973c-60a3ba029973. Confidence: reported (aggregated from official Illinois legislature records).